Provided by Tiger Fintech (Singapore) Pte. Ltd.

Pharvaris N.V.

22.99
-0.0100-0.04%
Post-market: 22.990.00000.00%16:11 EDT
Volume:559.45K
Turnover:12.95M
Market Cap:1.49B
PE:-6.33
High:23.49
Open:23.27
Low:22.54
Close:23.00
52wk High:26.33
52wk Low:11.51
Shares:64.95M
Float Shares:33.91M
Volume Ratio:2.78
T/O Rate:1.65%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.6336
EPS(LYR):-2.5724
ROE:-65.09%
ROA:-36.84%
PB:6.97
PE(LYR):-8.94

Loading ...

Pharvaris Unveils New Clinical Data on Oral Deucrictibant for Hereditary Angioedema at ACAAI 2025

Reuters
·
Oct 23

The Bull Case For Pharvaris (PHVS) Could Change Following Analyst Upgrades and Rising Institutional Interest

Simply Wall St.
·
Oct 19

Analysts Conflicted on These Healthcare Names: Abbott Laboratories (ABT), Amgen (AMGN) and Pharvaris (PHVS)

TIPRANKS
·
Oct 16

HC Wainwright Initiates Coverage on Pharvaris N.V With Buy Rating, $60 Price Target

MT Newswires Live
·
Oct 15

Pharvaris Initiated at Buy by HC Wainwright & Co.

Dow Jones
·
Oct 15

Pharvaris N.v. : H.c. Wainwright Initiates Coverage With Buy Rating

THOMSON REUTERS
·
Oct 15

Pharvaris initiated with a Buy at H.C. Wainwright

TIPRANKS
·
Oct 15

Analysts Offer Insights on Healthcare Companies: Galapagos (GLPG), Pharvaris (PHVS) and Stevanato Group (STVN)

TIPRANKS
·
Oct 13

Pharvaris Raised to Neutral From Underperform by B of A Securities

Dow Jones
·
Oct 09

Pharvaris upgraded to Neutral from Underperform at BofA

TIPRANKS
·
Oct 09

Morgan Stanley Keeps Their Buy Rating on Pharvaris (PHVS)

TIPRANKS
·
Sep 15

Pharvaris NV Announces New Registration Rights Agreement with General Atlantic PH B.V

Reuters
·
Sep 09

BofA Securities Adjusts Price Target on Pharvaris to $16 From $14, Maintains Underperform Rating

MT Newswires Live
·
Aug 15

Pharvaris NV reports results for the quarter ended June 30 - Earnings Summary

Reuters
·
Aug 13

Pharvaris Q2 EPS $(0.94) Misses $(0.87) Estimate

Benzinga
·
Aug 13

Pharvaris NV Announces Initiation of CREAATE Phase 3 Study for AAE-C1INH Treatment and Upcoming Topline Results for RAPIDe-3 in 4Q2025

Reuters
·
Aug 13

Pharvaris NV expected to post a loss of 77 cents a share - Earnings Preview

Reuters
·
Aug 09

Pharvaris Closes $201.2 Million Offering

MT Newswires Live
·
Jul 25

Pharvaris NV Closes $201.2 Million Upsized Public Offering of Ordinary Shares and Pre-Funded Warrants, Including Full Exercise of Underwriters' Option

Reuters
·
Jul 25

BUZZ-Drug developer Pharvaris falls after upsized $175 million raise

Reuters
·
Jul 24